XBiotech Inc. (XBIT)
NASDAQ·Healthcare·Biotechnology
$2.58
+0.20%
Mkt Cap $71.65M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 13, 2026 | $7.00M | — | — | $0.04 | -$0.88 | -2300.00% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | — | -$0.20 | — | — | — |
| Q3 2025 Aug 13, 2025 | — | — | — | — | -$0.06 | — | — | — |
| Q2 2025 May 14, 2025 | — | — | — | — | -$0.36 | — | — | — |
| Q1 2025 Mar 18, 2025 | — | — | — | — | -$0.34 | — | — | — |
| Q4 2024 Nov 13, 2024 | — | — | — | — | -$0.16 | — | — | — |
| Q3 2024 Aug 12, 2024 | $7.00M | — | — | — | -$0.43 | — | — | — |
| Q2 2024 May 10, 2024 | $7.00M | — | — | — | -$0.33 | — | — | — |
| Q1 2024 Mar 15, 2024 | $7.00M | $2.62M | -62.57% | — | -$0.16 | — | — | — |
| Q4 2023 Nov 9, 2023 | $7.00M | — | — | — | -$0.24 | — | — | — |
| Q3 2023 Aug 11, 2023 | $7.00M | — | — | — | -$0.29 | — | — | — |
| Q2 2023 May 10, 2023 | $7.00M | — | — | — | -$0.13 | — | — | — |
| Q1 2023 Mar 15, 2023 | $7.00M | $300.00K | -95.71% | — | -$0.10 | — | — | — |
| Q4 2022 Nov 9, 2022 | — | $1.68M | — | — | -$0.42 | — | — | — |
| Q3 2022 Aug 10, 2022 | $7.00M | $1.53M | -78.14% | — | -$0.38 | — | — | — |
| Q2 2022 May 10, 2022 | $7.00M | $500.00K | -92.86% | — | -$0.18 | — | — | — |
| Q1 2022 Mar 15, 2022 | $7.00M | $4.50M | -35.71% | $0.02 | -$0.21 | -1150.00% | — | — |
| Q4 2021 Nov 9, 2021 | $7.00M | $4.52M | -35.44% | $0.03 | -$0.11 | -466.67% | — | — |
| Q3 2021 Aug 9, 2021 | $7.00M | $4.53M | -35.36% | $0.03 | -$0.17 | -666.67% | — | — |
| Q2 2021 May 10, 2021 | $7.00M | $4.85M | -30.71% | $0.04 | -$0.09 | -325.00% | — | — |